C9ORF21 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.976400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.398000E-01
Normal-vs-Stage2
5.337400E-01
Normal-vs-Stage3
3.405800E-01
Normal-vs-Stage4
6.976000E-01
Stage1-vs-Stage2
7.194400E-01
Stage1-vs-Stage3
6.201200E-01
Stage1-vs-Stage4
1.317570E-01
Stage2-vs-Stage3
4.476800E-01
Stage2-vs-Stage4
1.802970E-01
Stage3-vs-Stage4
9.665600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.173600E-01
Normal-vs-AfricanAmerican
9.938200E-01
Normal-vs-Asian
1.837760E-01
Caucasian-vs-AfricanAmerican
4.772200E-01
Caucasian-vs-Asian
3.929700E-02
AfricanAmerican-vs-Asian
1.142800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.070400E-01
Normal-vs-Female
6.024600E-01
Male-vs-Female
6.650600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.214200E-01
Normal-vs-Age(41-60Yrs)
9.556400E-01
Normal-vs-Age(61-80Yrs)
4.234000E-01
Normal-vs-Age(81-100Yrs)
4.093400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.624600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.991000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.497600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.455600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.075610E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.712200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.626000E-01
Normal-vs-Daily Drinker
2.848800E-01
Normal-vs-Weekly Drinker
7.710800E-01
Normal-vs-Occasional Drinker
7.399800E-01
Normal-vs-Social Drinker
6.773200E-01
Non Drinker-vs-Daily Drinker
8.953000E-01
Non Drinker-vs-Weekly Drinker
2.188000E-01
Non Drinker-vs-Occasional Drinker
2.827200E-01
Non Drinker-vs-Social Drinker
3.244400E-01
Daily Drinker-vs-Weekly Drinker
2.022000E-01
Daily Drinker-vs-Occasional Drinker
3.044400E-01
Daily Drinker-vs-Social Drinker
3.264800E-01
Weekly Drinker-vs-Occasional Drinker
8.773800E-01
Weekly Drinker-vs-Social Drinker
8.089000E-01
Occasional Drinker-vs-Social Drinker
9.402600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.301000E-01
Normal-vs-Grade 2
9.131800E-01
Normal-vs-Grade 3
9.641200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.230000E-01
Grade 1-vs-Grade 3
9.092000E-01
Grade 1-vs-Grade 4
9.301000E-01
Grade 2-vs-Grade 3
4.122600E-01
Grade 2-vs-Grade 4
9.131800E-01
Grade 3-vs-Grade 4
9.641200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.286000E-01
Normal-vs-NonDiabetic
5.150000E-01
Diabetic-vs-NonDiabetic
9.881200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.051800E-01
Normal-vs-NoPancreatitis
5.845000E-01
Pancreatitis-vs-NoPancreatitis
1.974140E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.335000E-01
Normal-vs-N1
6.194600E-01
N0-vs-N1
5.334400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.338400E-01
Normal-vs-TP53-NonMutant
4.615200E-01
TP53-Mutant-vs-TP53-NonMutant
3.620200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
